ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Centers Survey Generates Only 56 Responses GAO to Report On NCI’s Dissemination Efforts

January 22, 1988

UICC Names Banker As Chief Executive

September 11, 2009

In Brief: Russos of Michigan Move To Fox Chase; Becker Named To Endowed Chair; NCI’s David Byar Dies

August 23, 1991

NCI Urged To Back Ultrasounds Studies

October 1, 1976

Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests

May 31, 2002

United Approach With Other Health Advocates Needed To Increase Cancer Dollars, Royboal Says

February 10, 1978